June 2, 2020 — Lunit announced that its artificial intelligence (AI) solution for breast cancer, Lunit INSIGHT MMG, has been CE certified. The medical software was certified on May 26, making it now commercially available across the European Economic Area, including 27 member countries of the European Union, United Kingdom, as well as the European Free Trade Association.

June 1, 2020 — While acknowledging the challenges their specialty is facing, more than two-thirds of respondents to an American Society of Nuclear Cardiology (ASNC) member survey are confident nuclear cardiology volumes will return to pre-pandemic levels. 

June 1, 2020 — RaySearch Laboratories AB and Varian Medical Systems have entered into an interoperability agreement that will allow the RayCare oncology information system to connect to Varian TrueBeam linear accelerators.

June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography (PET) imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease (AD). A neuropathological diagnosis of AD requires the demonstration of the presence of both b

June 1, 2020 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) for treating all stages of cancer, announced a clinical collaboration with Merck to evaluate the safety and efficacy of KEYTRUDA (pembrolizumab), Merck’s anti-PD-1 therapy, in combination with BgRT in multiple late-stage canc

May 29, 2020 — GE Healthcare announced U.S. FDA 510(k) clearance of AIR Recon DL. This pioneering technology, using a deep learning-based neural network, improves the patient experience through shorter scan times while also increasing diagnostic confidence with better image quality across all anatomies.

May 29, 2020 — An investigation published open-access in the American Journal of Roentgenology (AJR) revealed a high frequency of negative chest computed tomography (CT) findings among pediatric patients with laboratory-confirmed coronavirus disease (COVID-19), while also suggesting that bilateral, lower lobe-predominant ground-glass opacities (GGOs) are common in the su

Houston Northwest Radiology Association (HNRA) was looking for a PACS solution that would support their growing business and grow with them. HNRA was adding practices at a rapid rate across a broad geography and needed a solution that could accommodate seamless connectivity without disrupting operations and was user friendly for easy adoption.

May 27, 2020 — PETNET Solutions, Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of Zionexa SAS, have announced that the Food and Drug Administration (FDA) has approved Cerianna (fluoroestradiol F 18) injection for intravenous use.


One year after being proposed, federal rules to advance interoperability in healthcare and create easier access for patients to obtain and control their medical data were finalized.


Subscribe Now